PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS

Abstract: provided herein are compounds, methods and compositions for determining whether a patient has a neurological disease or disorder is provided, comprising detecting the presence of a detectable target protein, or an accumulated mass thereof, for example, amyloid beta protein or phosphorylated tau protein, or an accumulated mass thereof, in a tissue or a sample of the patient. the detecting may comprise contacting the target protein with a compound described herein.

Inventor(s): Stella Sarraf, Lyndsay M. Randolph, Suhail RasooI

CPC Classification: A61K49/0021 (Preparations for testing in vivo)

Search for rejections for patent application number 20250213732